Skip to content

Clinical trials

Terminated Carcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Status: Terminated Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20051
20064
20072
20087
20094
20104
20111
20121
20131
20146
20153
20161
20173
20182
20193
20205
20214
20224
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation3
Abbott2
Astellas Pharma Inc2
Inovio Pharmaceuticals2
National Cancer Institute (NCI)2
Novartis Pharmaceuticals2
University of Florida2
University of Pittsburgh2
Aegera Therapeutics1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma62
Neoplasms26
Carcinoma, Non-Small-Cell Lung13
Neoplasm Metastasis11
Adenocarcinoma9
Carcinoma, Renal Cell8
Neoplasms by Site8
Carcinoma, Squamous Cell7
Colorectal Neoplasms7
Lung Neoplasms7

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.